These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 23362162

  • 1. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
    Tuononen K, Mäki-Nevala S, Sarhadi VK, Wirtanen A, Rönty M, Salmenkivi K, Andrews JM, Telaranta-Keerie AI, Hannula S, Lagström S, Ellonen P, Knuuttila A, Knuutila S.
    Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
    [Abstract] [Full Text] [Related]

  • 2. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG.
    Int J Clin Exp Pathol; 2013 May; 6(9):1880-9. PubMed ID: 24040454
    [Abstract] [Full Text] [Related]

  • 3. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 4. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D, Snijders PJ, Meijer GA, Doeleman MW, van Moorsel MI, van Essen HF, Eijk PP, Grünberg K, van Grieken NC, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DA.
    Cell Oncol (Dordr); 2014 Oct 15; 37(5):353-61. PubMed ID: 25209392
    [Abstract] [Full Text] [Related]

  • 5. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Oct 15; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M.
    BMC Cancer; 2011 Sep 24; 11():406. PubMed ID: 21943394
    [Abstract] [Full Text] [Related]

  • 7. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H, Krypuy M, Mitchell PL, Fox SB, Dobrovic A.
    BMC Cancer; 2008 May 21; 8():142. PubMed ID: 18495026
    [Abstract] [Full Text] [Related]

  • 8. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
    Lewandowska MA, Jóźwicki W, Żurawski B.
    Mol Diagn Ther; 2013 Jun 21; 17(3):193-203. PubMed ID: 23606169
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Next-Generation Sequencing, Quantitative PCR, and Sanger Sequencing for Mutation Profiling of EGFR, KRAS, PIK3CA and BRAF in Clinical Lung Tumors.
    Gao J, Wu H, Shi X, Huo Z, Zhang J, Liang Z.
    Clin Lab; 2016 Jun 21; 62(4):689-96. PubMed ID: 27215089
    [Abstract] [Full Text] [Related]

  • 10. Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.
    Lewandowska MA, Jóźwicki W, Jochymski C, Kowalewski J.
    Oncol Rep; 2013 Sep 21; 30(3):1045-52. PubMed ID: 23817662
    [Abstract] [Full Text] [Related]

  • 11. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug 21; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

  • 12. Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.
    Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR.
    Am J Clin Pathol; 2014 Jun 21; 141(6):856-66. PubMed ID: 24838331
    [Abstract] [Full Text] [Related]

  • 13. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S, Satapathy A, Aggarwal A, Dewan A, Jain E, Katara R, Kumar V, Pal R, Pandey S, Naidu MM, Kini L, Pradhan D, Mohanty SK.
    Pathol Res Pract; 2021 Apr 21; 220():153394. PubMed ID: 33706124
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.
    Chevrier S, Arnould L, Ghiringhelli F, Coudert B, Fumoleau P, Boidot R.
    Int J Oncol; 2014 Sep 21; 45(3):1167-74. PubMed ID: 24990411
    [Abstract] [Full Text] [Related]

  • 16. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ, Lee SE, Kang SY, Choi YL.
    Pathol Res Pract; 2011 Dec 15; 207(12):762-8. PubMed ID: 22070922
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X, Wang Y, Gao N, Wang J.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 15; 43(2):77-82. PubMed ID: 24742565
    [Abstract] [Full Text] [Related]

  • 20. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    Franczak C, Dubouis L, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harlé A.
    PLoS One; 2019 Feb 15; 14(2):e0212801. PubMed ID: 30811471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.